Status:
COMPLETED
Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study
Lead Sponsor:
National Skin Centre
Conditions:
Melasma
Eligibility:
All Genders
25-70 years
Phase:
PHASE2
Brief Summary
The goal of this clinical trial is to learn if Eflornithine hydrochloride cream works to treat melasma in adults, in comparison to Hydroquinone cream. It will also learn about the safety of Eflornithi...
Eligibility Criteria
Inclusion
- Clinical diagnosis of melasma
- Fitzpatrick Type III or IV
- Able to provide informed consent
Exclusion
- Pregnant or lactating patients
- Patients with difficulty adhering to regular topical treatments
- Patients with known contact allergies to any of the ingredients in the topical medications used in the study
Key Trial Info
Start Date :
June 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06957834
Start Date
June 6 2023
End Date
July 11 2024
Last Update
May 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Skin Centre
Singapore, Singapore